Industry: Medical Devices & Consumables
Published Date: 2024-08-22
Pages: 101 Pages
Report ld: 3291532
Request Sample
Customized Report
Phrenic Nerve Stimulator (PNS) Market Size(US$)

CAGR 2024-2030
5.5%
Market Size,2030
USD 8.4
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Phrenic nerve stimulationis also known as diaphragm pacing. It achieves the purpose of improving ventilation by causing diaphragm contraction through functional electrical stimulation of the phrenic nerve. There are two types of stimulators: implantable stimulators and non-invasive external stimulators.
The global market for Phrenic Nerve Stimulator (PNS) was estimated to be worth US$ 5.8 million in 2023 and is forecast to a readjusted size of US$ 8.4 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030.
North American market for Phrenic Nerve Stimulator (PNS) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Phrenic Nerve Stimulator (PNS) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Phrenic Nerve Stimulator (PNS) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Phrenic Nerve Stimulator (PNS) include Avery Biomedical Devices, Synapse Biomedical, Atrotech, Lungpacer Medical, ZOLL, Arahelio, Gaemi Medical, Guangzhou TAKO, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Phrenic Nerve Stimulator (PNS), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Phrenic Nerve Stimulator (PNS) by region & country, by Type, and by Application.
The Phrenic Nerve Stimulator (PNS) market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phrenic Nerve Stimulator (PNS).
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Phrenic Nerve Stimulator (PNS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Phrenic Nerve Stimulator (PNS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Phrenic Nerve Stimulator (PNS) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Phrenic Nerve Stimulator (PNS) Product Introduction
1.2 Global Phrenic Nerve Stimulator (PNS) Market Size Forecast
1.2.1 Global Phrenic Nerve Stimulator (PNS) Sales Value (2019-2030)
1.2.2 Global Phrenic Nerve Stimulator (PNS) Sales Volume (2019-2030)
1.2.3 Global Phrenic Nerve Stimulator (PNS) Sales Price (2019-2030)
1.3 Phrenic Nerve Stimulator (PNS) Market Trends & Drivers
1.3.1 Phrenic Nerve Stimulator (PNS) Industry Trends
1.3.2 Phrenic Nerve Stimulator (PNS) Market Drivers & Opportunity
1.3.3 Phrenic Nerve Stimulator (PNS) Market Challenges
1.3.4 Phrenic Nerve Stimulator (PNS) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Phrenic Nerve Stimulator (PNS) Players Revenue Ranking (2023)
2.2 Global Phrenic Nerve Stimulator (PNS) Revenue by Company (2019-2024)
2.3 Global Phrenic Nerve Stimulator (PNS) Players Sales Volume Ranking (2023)
2.4 Global Phrenic Nerve Stimulator (PNS) Sales Volume by Company Players (2019-2024)
2.5 Global Phrenic Nerve Stimulator (PNS) Average Price by Company (2019-2024)
2.6 Key Manufacturers Phrenic Nerve Stimulator (PNS) Manufacturing Base and Headquarters
2.7 Key Manufacturers Phrenic Nerve Stimulator (PNS) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Phrenic Nerve Stimulator (PNS)
2.9 Phrenic Nerve Stimulator (PNS) Market Competitive Analysis
2.9.1 Phrenic Nerve Stimulator (PNS) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Phrenic Nerve Stimulator (PNS) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phrenic Nerve Stimulator (PNS) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Implantable Stimulator
3.1.2 External Stimulator
3.2 Global Phrenic Nerve Stimulator (PNS) Sales Value by Type
3.2.1 Global Phrenic Nerve Stimulator (PNS) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Phrenic Nerve Stimulator (PNS) Sales Value, by Type (2019-2030)
3.2.3 Global Phrenic Nerve Stimulator (PNS) Sales Value, by Type (%) (2019-2030)
3.3 Global Phrenic Nerve Stimulator (PNS) Sales Volume by Type
3.3.1 Global Phrenic Nerve Stimulator (PNS) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Phrenic Nerve Stimulator (PNS) Sales Volume, by Type (2019-2030)
3.3.3 Global Phrenic Nerve Stimulator (PNS) Sales Volume, by Type (%) (2019-2030)
3.4 Global Phrenic Nerve Stimulator (PNS) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Spinal Cord Injury
4.1.2 Central Sleep Apnea
4.1.3 Amyotrophic Lateral Sclerosis
4.1.4 Others
4.2 Global Phrenic Nerve Stimulator (PNS) Sales Value by Application
4.2.1 Global Phrenic Nerve Stimulator (PNS) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Phrenic Nerve Stimulator (PNS) Sales Value, by Application (2019-2030)
4.2.3 Global Phrenic Nerve Stimulator (PNS) Sales Value, by Application (%) (2019-2030)
4.3 Global Phrenic Nerve Stimulator (PNS) Sales Volume by Application
4.3.1 Global Phrenic Nerve Stimulator (PNS) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Phrenic Nerve Stimulator (PNS) Sales Volume, by Application (2019-2030)
4.3.3 Global Phrenic Nerve Stimulator (PNS) Sales Volume, by Application (%) (2019-2030)
4.4 Global Phrenic Nerve Stimulator (PNS) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Phrenic Nerve Stimulator (PNS) Sales Value by Region
5.1.1 Global Phrenic Nerve Stimulator (PNS) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Phrenic Nerve Stimulator (PNS) Sales Value by Region (2019-2024)
5.1.3 Global Phrenic Nerve Stimulator (PNS) Sales Value by Region (2025-2030)
5.1.4 Global Phrenic Nerve Stimulator (PNS) Sales Value by Region (%), (2019-2030)
5.2 Global Phrenic Nerve Stimulator (PNS) Sales Volume by Region
5.2.1 Global Phrenic Nerve Stimulator (PNS) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Phrenic Nerve Stimulator (PNS) Sales Volume by Region (2019-2024)
5.2.3 Global Phrenic Nerve Stimulator (PNS) Sales Volume by Region (2025-2030)
5.2.4 Global Phrenic Nerve Stimulator (PNS) Sales Volume by Region (%), (2019-2030)
5.3 Global Phrenic Nerve Stimulator (PNS) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
5.4.2 North America Phrenic Nerve Stimulator (PNS) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
5.5.2 Europe Phrenic Nerve Stimulator (PNS) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
5.6.2 Asia Pacific Phrenic Nerve Stimulator (PNS) Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
5.7.2 South America Phrenic Nerve Stimulator (PNS) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
5.8.2 Middle East & Africa Phrenic Nerve Stimulator (PNS) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Phrenic Nerve Stimulator (PNS) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Phrenic Nerve Stimulator (PNS) Sales Value
6.2.1 Key Countries/Regions Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Phrenic Nerve Stimulator (PNS) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
6.3.2 United States Phrenic Nerve Stimulator (PNS) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Phrenic Nerve Stimulator (PNS) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
6.4.2 Europe Phrenic Nerve Stimulator (PNS) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Phrenic Nerve Stimulator (PNS) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
6.5.2 China Phrenic Nerve Stimulator (PNS) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Phrenic Nerve Stimulator (PNS) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
6.6.2 Japan Phrenic Nerve Stimulator (PNS) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Phrenic Nerve Stimulator (PNS) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
6.7.2 South Korea Phrenic Nerve Stimulator (PNS) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Phrenic Nerve Stimulator (PNS) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
6.8.2 Southeast Asia Phrenic Nerve Stimulator (PNS) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Phrenic Nerve Stimulator (PNS) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Phrenic Nerve Stimulator (PNS) Sales Value, 2019-2030
6.9.2 India Phrenic Nerve Stimulator (PNS) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Phrenic Nerve Stimulator (PNS) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Avery Biomedical Devices
7.1.1 Avery Biomedical Devices Company Information
7.1.2 Avery Biomedical Devices Introduction and Business Overview
7.1.3 Avery Biomedical Devices Phrenic Nerve Stimulator (PNS) Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Avery Biomedical Devices Phrenic Nerve Stimulator (PNS) Product Offerings
7.1.5 Avery Biomedical Devices Recent Development
7.2 Synapse Biomedical
7.2.1 Synapse Biomedical Company Information
7.2.2 Synapse Biomedical Introduction and Business Overview
7.2.3 Synapse Biomedical Phrenic Nerve Stimulator (PNS) Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Synapse Biomedical Phrenic Nerve Stimulator (PNS) Product Offerings
7.2.5 Synapse Biomedical Recent Development
7.3 Atrotech
7.3.1 Atrotech Company Information
7.3.2 Atrotech Introduction and Business Overview
7.3.3 Atrotech Phrenic Nerve Stimulator (PNS) Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Atrotech Phrenic Nerve Stimulator (PNS) Product Offerings
7.3.5 Atrotech Recent Development
7.4 Lungpacer Medical
7.4.1 Lungpacer Medical Company Information
7.4.2 Lungpacer Medical Introduction and Business Overview
7.4.3 Lungpacer Medical Phrenic Nerve Stimulator (PNS) Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Lungpacer Medical Phrenic Nerve Stimulator (PNS) Product Offerings
7.4.5 Lungpacer Medical Recent Development
7.5 ZOLL
7.5.1 ZOLL Company Information
7.5.2 ZOLL Introduction and Business Overview
7.5.3 ZOLL Phrenic Nerve Stimulator (PNS) Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 ZOLL Phrenic Nerve Stimulator (PNS) Product Offerings
7.5.5 ZOLL Recent Development
7.6 Arahelio
7.6.1 Arahelio Company Information
7.6.2 Arahelio Introduction and Business Overview
7.6.3 Arahelio Phrenic Nerve Stimulator (PNS) Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Arahelio Phrenic Nerve Stimulator (PNS) Product Offerings
7.6.5 Arahelio Recent Development
7.7 Gaemi Medical
7.7.1 Gaemi Medical Company Information
7.7.2 Gaemi Medical Introduction and Business Overview
7.7.3 Gaemi Medical Phrenic Nerve Stimulator (PNS) Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Gaemi Medical Phrenic Nerve Stimulator (PNS) Product Offerings
7.7.5 Gaemi Medical Recent Development
7.8 Guangzhou TAKO
7.8.1 Guangzhou TAKO Company Information
7.8.2 Guangzhou TAKO Introduction and Business Overview
7.8.3 Guangzhou TAKO Phrenic Nerve Stimulator (PNS) Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Guangzhou TAKO Phrenic Nerve Stimulator (PNS) Product Offerings
7.8.5 Guangzhou TAKO Recent Development
8 Industry Chain Analysis
8.1 Phrenic Nerve Stimulator (PNS) Industrial Chain
8.2 Phrenic Nerve Stimulator (PNS) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Phrenic Nerve Stimulator (PNS) Sales Model
8.5.2 Sales Channel
8.5.3 Phrenic Nerve Stimulator (PNS) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Phrenic Nerve Stimulator (PNS) market is projected to grow from US$ 29.00 million in 2025 to US$ 44.29 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-11
Pages: 146
USD 4900.00
(Single User License)
The global Phrenic Nerve Stimulator (PNS) market size was US$ 29.00 million in 2025 and is forecast to reach a readjusted size of US$ 44.29 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-07-11
Pages: 132
USD 4250.00
(Single User License)
The global market for Phrenic Nerve Stimulator (PNS) was estimated to be worth US$ 29.00 million in 2025 and is projected to reach US$ 44.29 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 133
USD 3950.00
(Single User License)
The global Phrenic Nerve Stimulator (PNS) market was valued at US$ 29.00 million in 2025 and is anticipated to reach US$ 44.29 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 111
USD 2900.00
(Single User License)
The global Phrenic Nerve Stimulator (PNS) market is projected to grow from US$ 6.1 million in 2024 to US$ 8.8 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 135
USD 4900.00
(Single User License)
The global Phrenic Nerve Stimulator (PNS) market size was US$ 6.1 million in 2024 and is forecast to a readjusted size of US$ 8.8 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 79
USD 4250.00
(Single User License)
The global market for Phrenic Nerve Stimulator (PNS) was estimated to be worth US$ 6.1 million in 2024 and is forecast to a readjusted size of US$ 8.8 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 107
USD 3950.00
(Single User License)
The global market for Phrenic Nerve Stimulator (PNS) was valued at US$ 6.1 million in the year 2024 and is projected to reach a revised size of US$ 8.8 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published Date: 2025-03-10
Pages: 80
USD 2900.00
(Single User License)
Phrenic nerve stimulationis also known as diaphragm pacing. It achieves the purpose of improving ventilation by causing diaphragm contraction through functional electrical stimulation of the phrenic nerve. There are two types of stimulators: implantable stimulators and non-invasive external stimulators.
Published Date: 2024-08-22
Pages: 106
USD 4350.00
(Single User License)
Phrenic nerve stimulationis also known as diaphragm pacing. It achieves the purpose of improving ventilation by causing diaphragm contraction through functional electrical stimulation of the phrenic nerve. There are two types of stimulators: implantable stimulators and non-invasive external stimulators.
Published Date: 2024-08-22
Pages: 81
USD 2900.00
(Single User License)
The global Phrenic Nerve Stimulator (PNS) market is projected to grow from US$ 29.00 million in 2025 to US$ 44.29 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-11
Pages: 146
The global Phrenic Nerve Stimulator (PNS) market size was US$ 29.00 million in 2025 and is forecast to reach a readjusted size of US$ 44.29 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-07-11
Pages: 132
The global market for Phrenic Nerve Stimulator (PNS) was estimated to be worth US$ 29.00 million in 2025 and is projected to reach US$ 44.29 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-11
Pages: 133
The global Phrenic Nerve Stimulator (PNS) market was valued at US$ 29.00 million in 2025 and is anticipated to reach US$ 44.29 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-11
Pages: 111
The global Phrenic Nerve Stimulator (PNS) market is projected to grow from US$ 6.1 million in 2024 to US$ 8.8 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 135
The global Phrenic Nerve Stimulator (PNS) market size was US$ 6.1 million in 2024 and is forecast to a readjusted size of US$ 8.8 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 79
The global market for Phrenic Nerve Stimulator (PNS) was estimated to be worth US$ 6.1 million in 2024 and is forecast to a readjusted size of US$ 8.8 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 107
The global market for Phrenic Nerve Stimulator (PNS) was valued at US$ 6.1 million in the year 2024 and is projected to reach a revised size of US$ 8.8 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-03-10
Pages: 80
Phrenic nerve stimulationis also known as diaphragm pacing. It achieves the purpose of improving ventilation by causing diaphragm contraction through functional electrical stimulation of the phrenic nerve. There are two types of stimulators: implantable stimulators and non-invasive external stimulators.
Published: 2024-08-22
Pages: 106
Phrenic nerve stimulationis also known as diaphragm pacing. It achieves the purpose of improving ventilation by causing diaphragm contraction through functional electrical stimulation of the phrenic nerve. There are two types of stimulators: implantable stimulators and non-invasive external stimulators.
Published: 2024-08-22
Pages: 81
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now